Systemic delivery of oncolytic herpes virus using CAR-T cells enhances targeting of antitumor immuno-virotherapy

Z Zhang, N Yang, L Xu, H Lu, Y Chen, Z Wang… - Cancer Immunology …, 2024 - Springer
Recent studies have indicated that combining oncolytic viruses with CAR-T cells in therapy
has shown superior anti-tumor effects, representing a promising approach. Nonetheless, the …

[HTML][HTML] IGF2BP3 Enhances the Growth of Hepatocellular Carcinoma Tumors by Regulating the Properties of Macrophages and CD8+ T Cells in the Tumor …

L Ma, J Jiang, Q Si, C Chen, Z Duan - Journal of Clinical and …, 2023 - ncbi.nlm.nih.gov
Methods The relationship between IGF2BP3 and immune cell infiltration was analyzed using
online bioinformatics tools. Knockout of IGF2BP3 in mouse hepatoma cell line Hepa1-6 was …

合成生物学在基于微生物载体肿瘤疫苗设计中的应用

谭子斌, 梁康, 陈有海 - 合成生物学, 2024 - synbioj.cip.com.cn
合成生物学有望创造具备独特优势的抗肿瘤微生物疫苗, 合成生物学改造的微生物更能适应肿瘤
微环境并在其中富集与增殖, 削弱或者逆转免疫抑制细胞的功能, 并增强肿瘤抗原的呈递 …

Bispecific T-cell engagers and chimeric antigen receptor T-cell therapies in glioblastoma: an update

R Alsajjan, WP Mason - Current Oncology, 2023 - mdpi.com
Glioblastoma is the most common malignant primary brain tumor in adults. The prognosis is
extremely poor even with standard treatment of maximal safe resection, radiotherapy, and …

The Cytotoxic Cardiac Glycoside (−)-Cryptanoside A from the Stems of Cryptolepis dubia and Its Molecular Targets

Y Ren, EN Kaweesa, L Tian, S Wu… - Journal of Natural …, 2023 - ACS Publications
A cardiac glycoside epoxide,(−)-cryptanoside A (1), was isolated from the stems of
Cryptolepis dubia collected in Laos, for which the complete structure was confirmed by …

Oncolytic viral therapy for gliomas: Advances in the mechanisms and approaches to delivery

A Romanishin, A Vasilev, E Khasanshin, A Evtekhov… - Virology, 2024 - Elsevier
Glioma is a diverse category of tumors originating from glial cells encompasses various
subtypes, based on the specific type of glial cells involved. The most aggressive is …

Eravacycline improves the efficacy of anti-PD1 immunotherapy via AP1/CCL5 mediated M1 macrophage polarization in melanoma

N Liu, M Yan, C Lu, Q Tao, J Wu, Z Zhou, J Chen… - Biomaterials, 2024 - Elsevier
Screening approved library is a promising and safe strategy to overcome the limitation of low
response rate and drug resistance in immunotherapy. Accumulating evidences showed that …

Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives

H Lin, C Liu, A Hu, D Zhang, H Yang, Y Mao - Journal of Hematology & …, 2024 - Springer
Glioblastoma (GBM), the predominant and primary malignant intracranial tumor, poses a
formidable challenge due to its immunosuppressive microenvironment, thereby confounding …

Arming oncolytic viruses with bispecific T cell engagers: The evolution and current status

Y Wang, P Cheng - Biochimica et Biophysica Acta (BBA)-Molecular Basis …, 2023 - Elsevier
Oncolytic viruses (OVs) are emerging as therapeutically relevant anticancer agents as
contemporary immunotherapy gains traction. Furthermore, OVs are an ideal platform for …

Tuning Cellular Metabolism for Cancer Virotherapy

D Xiong, Q Wang, WM Wang, ZJ Sun - Cancer Letters, 2024 - Elsevier
Oncolytic viruses (OVs) represent an emerging immunotherapeutic strategy owing to their
capacity for direct tumor lysis and induction of antitumor immunity. However, hurdles like …